Reliability of Friedewald formula in patients with type 2 diabetes mellitus and its relation to lipid profile in diabetes regulation

1. Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Circulation. 2019 Jun;139(25):1082-143. DOI: 10.1161/CIR.000000000000069810.1161/CIR.000000000000069831206330Search in Google Scholar

2. Catapano AL, Graham I, Backer GD, Wiklund O, Chapman MJ, Drexel H, et al. 2016 ESC/EAS guidelines for the management of dyslipidaemias. Eur Heart J. 2016 Aug;37 (39):2999-3058. DOI: 10.1093/eurheartj/ehw27210.1093/eurheartj/ehw27227567407Search in Google Scholar

3. Kapoor R, Chakraborty M, Singh NA. Leap above Friedewald formula for calculation of lowdensity lipoprotein cholesterol. J Lab Physicians. 2015 Jan-Jun;7(1):11-6. DOI: 10.4103/0974-2727.15478010.4103/0974-2727.154780441180325949053Search in Google Scholar

4. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultra-centrifuge. Clin Chem. 1972 Jun;18(6):499-502. DOI: 10.1093/clinchem/18.6.49910.1093/clinchem/18.6.499Search in Google Scholar

5. Jialal I, Gounden V. Reporting LDL cholesterol levels in the era of intensive lipid management: a clarion call. Clin Chem Lab Med. 2017 Aug;55(10):1447-9. DOI: 10.1515/cclm-2017-063910.1515/cclm-2017-063928796640Search in Google Scholar

6. Esteban-Salan M, Aguilar-Doreste JA, Arranz-Pena ML, Juve-Cuxart S, Gich-Salarich I, Zapico-Muniz E, et al. Multi-centric evaluation of the homogeneous LDL cholesterol plus assay: comparison with beta-quantification and Friedewald formula. J Clin Biochem. 2008 Nov;41(16-17):1402-9. DOI: 10.1016/j. clinbiochem.2008.07.014Search in Google Scholar

7. Fawwad A, Sabir R, Riaz M, Moin H, Basit A. Measured versus calculated LDL cholesterol in subjects with type 2 diabetes. Pak J Med Sci. 2016 Jul-Aug;32(4):955-60. DOI: 10.12669/pjms.324.989610.12669/pjms.324.9896501711027648047Search in Google Scholar

8. Chai Kheng EY, Chee Fang S, Chang S, Kiat Mun SL, Su Chi L, Lee Ying Y, et al. Low-density lipoprotein cholesterol levels in adults with type 2 diabetes: an alternative equation for accurate estimation and improved cardiovascular risk classification. Diab Vasc Dis Res. 2014 Nov;11(6):431-9. DOI: 10.1177/147916411454770310.1177/147916411454770325205607Search in Google Scholar

9. Jialal I, Singh G. Management of diabetic dyslipidemia: an update. World J Diabetes. 2019 May;10(5):280-90. DOI: 10.4239/wjd.v10.i5.28010.4239/wjd.v10.i5.280652275631139315Search in Google Scholar

10. Su X, Kong Y, Peng D. Evidence for changing lipid management strategy to focus on non-high density lipoprotein cholesterol. Lipids Health Dis. 2019 Jun;18(1):134. DOI: 10.1186/s12944-019-1080-x10.1186/s12944-019-1080-x655487731170997Search in Google Scholar

11. Boizel R, Benhamou PY, Lardy B, Laporte F, Foulon T, Halimi S. Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels. Diabetes Care. 2000 Nov;23(11):1679-85. DOI: 10.2337/diacare.23.11.167910.2337/diacare.23.11.167911092292Search in Google Scholar

12. da Luz PL, Favarato D, Faria-Neto Junior JR, Lemos P, Chagas ACP. High ratio of triglycerides to HDL-cholesterol predicts extensive coronary disease. Clinics. 2008 Aug;63(4):427-32. DOI: 10.1590/S1807-5932200800040000310.1590/S1807-59322008000400003Search in Google Scholar

13. Cholesterol Reference Method Laboratory Network (CRMLN). National reference system for cholesterol. LDL cholesterol method certification protocol for manufacturers. 2006.1-13.Search in Google Scholar

14. Mora S, Rifai S, Buring JE, Ridker PM. Comparison of LDL cholesterol concentrations by Friedewald calculation and direct measurement in relation to cardiovascular events in 27331 women. Clin Chem. 2009 May;55(5):888-94. DOI: 10.1373/clinchem.2008.11792910.1373/clinchem.2008.117929269288819395440Search in Google Scholar

15. Chatterjee BP, Sendhav S, Kakaiya A, Biswas PC. A comparative analysis of direct LDL-C assay and Friedewald’s formula in subjects of ischemic heart disease & stroke in a tertiary care centre. Int J Clin Biochem Res. 2018 July;5(4):541-6. DOI: 10.18231/2394-6377.2018.011510.18231/2394-6377.2018.0115Search in Google Scholar

16. Anwar M, Khan DA, Khan FA. Comparison of Friedewald formula and modified Friedewald formula with direct homogeneous assay for low density lipoprotein cholesterol estimation. J Coll Physicians Surg Pak. 2014 Jan;24(1):8-12.Search in Google Scholar

17. LeeJ, Jang S, Jeong H, Ryu OH. Validation of the Friedewald formula for estimating low density lipo-protein cholesterol: the Korea National Health and Nutrition Examination Survey, 2009 to 2011. Korean J Intern Med. 2020 Jan;35(1):150-9. DOI: 10.3904/kjim.2017.23310.3904/kjim.2017.233696004229551052Search in Google Scholar

18. Martin SS, Blaha MJ, Elshazly MB, Brinton EA, Toth PP, McEvoy JW, et al. Friedewald-estimated versus directly measured low-density lipoprotein cholesterol and treatment implications. J Am Coll Cardiol. 2013 Aug;62(8):732-9. DOI: 10.1016/j.jacc.2013.01.07910.1016/j.jacc.2013.01.07923524048Search in Google Scholar

19. Bansal E, Kaur N. Does Friedewald formula underestimate the risk of ischemic heart disease? Indian J Clin Biochem. 2014 Oct;29(4):496-500. DOI: 10.1007/s12291-013-0392-210.1007/s12291-013-0392-2417569825298632Search in Google Scholar

20. Esawya MM, Shabanaa MA, Magdyb MM. Evaluation of Martin’s equation for LDL-C estimation in type 2 diabetes mellitus Egyptian patients. Clin Chim Acta. 2019 Aug;495:487-92. DOI: 10.1016/j.cca.2019.05.02510.1016/j.cca.2019.05.02531145894Search in Google Scholar

21. Kurniawan LB, Windarwati W, Mulyono B. Analysis of LDL-C measurement using direct and Friedewald formula in type 2 diabetes mellitus patients. Indonesian J Clin Pathol Med Lab. 2018 July;24(3):255-7. DOI: 10.24293/ijcpml.v24i3.133910.24293/ijcpml.v24i3.1339Search in Google Scholar

22. Razi F, Forouzanfar K, Bandarian F, Nasli-Esfahani E. LDL-cholesterol measurement in diabetic type 2 patients: a comparison between direct assay and popular equations. J Diabetes Metab Disord. 2017 Nov;16:43. DOI: 10.1186/s40200-017-0326-210.1186/s40200-017-0326-2567052529142884Search in Google Scholar

23. Enkhmaa B, Prakash N, Berglund L. Non-HDL-C levels and residual cardiovascular risk: do population-specific precision approaches offer any advantages? Atherosclerosis. 2018 Jul;274:230-1. DOI: 10.1016/j.atherosclerosis.2018.05.01010.1016/j.atherosclerosis.2018.05.010709867229764695Search in Google Scholar

24. Mora S, Buring JE, Ridker PM. Discordance of low-density lipoprotein (LDL) cholesterol with alternative LDL-related measures and future coronary events. Circulation. 2014 Feb;129(5):553-61. DOI: 10.1161/CIRCULATIONAHA.113.00587310.1161/CIRCULATIONAHA.113.005873450125224345402Search in Google Scholar

25. Sudha K, Ashok P, Kiran KAM, Aradhana M, Anupama H. Validation of the Friedewald formula in type II diabetes mellitus: an Indian perspective study. Int J Biomed Adv Res. 2015 Feb;6(2):103-6. DOI: 10.7439/ijbar.v6i2.158110.7439/ijbar.v6i2.1581Search in Google Scholar

26. Viera PL, Araujo GN, Telo GH, Smidt LFS, Jost MF, Furtado MV,et al. Low-density lipoprotein values estimated by Friedewald equation are affected by diabetes control. Int J Cardiovasc Sci. 2016 Aug;29(5):348-54. DOI: 10.5935/2359-4802.2016004510.5935/2359-4802.20160045Search in Google Scholar

27. Mahato RV, Gyawali P, Raut PP, Regmi P, Singh KP, Pandeya DR, et al. Association between glycaemic control and serum lipid profile in type 2 diabetic patients: glycated haemoglobin as a dual biomarker. Biomed Res. 2011 March;22(3):375-80.Search in Google Scholar

28. Dong QT, Gao Y,Wu NQ, Guo YL, Zhu CG, Li S, et al. Impact of glucose and lipid markers on the correlation of calculated and enzymatic measured low-density lipoprotein cholesterol in diabetic patients with coronary artery disease. J Clin Lab Anal. 2018 Jun;32(5):e22399. DOI: 10.1002/jcla.2239910.1002/jcla.22399681691729380428Search in Google Scholar

29. Babic N, Valjevac A, Zaciragic A, Avdagic N, Zukic S, Hasic S. The triglyceride/HDL ratio and triglyceride glucose index as predictors of glycemic control in patients with diabetes mellitus type 2. Med Arch. 2019 Jun;73(3):163-8. DOI: 10.5455/medarh.2019.73.163-16810.5455/medarh.2019.73.163-168664332831404127Search in Google Scholar

30. Ozder A. Lipid profile abnormalities seen in T2 DM patients in primary Health care in Turkey: a cross-sectional study. Lipids Health Dis. 2014 Dec;13:183. DOI: 10.1186/1476-511X-13-18310.1186/1476-511X-13-183427148525481115Search in Google Scholar

31. Rubies-Prat J, Reverter JL, Sentí M, Pedro-Botet J, Salinas I, Lucas A, et al. Calculated low-density lipo-protein cholesterol should not be used for management of lipoprotein abnormalities in patients with diabetes mellitus. Diabetes Care. 1993 Aug;16(8):1081-6. DOI: 10.2337/diacare.16.8.108110.2337/diacare.16.8.10818375237Search in Google Scholar